Actinium Pharmaceuticals Statistics Share Statistics Actinium Pharmaceuticals has 31.2M
shares outstanding. The number of shares has increased by 0.13%
in one year.
Shares Outstanding 31.2M Shares Change (YoY) 0.13% Shares Change (QoQ) 0% Owned by Institutions (%) 26.28% Shares Floating 30.86M Failed to Deliver (FTD) Shares 4,260 FTD / Avg. Volume 1.72%
Short Selling Information The latest short interest is 875.94K, so 2.81% of the outstanding
shares have been sold short.
Short Interest 875.94K Short % of Shares Out 2.81% Short % of Float 2.81% Short Ratio (days to cover) 6.42
Valuation Ratios The PE ratio is -0.99 and the forward
PE ratio is -1.57.
Actinium Pharmaceuticals's PEG ratio is
0.03.
PE Ratio -0.99 Forward PE -1.57 PS Ratio 0 Forward PS 3.9 PB Ratio 1.16 P/FCF Ratio -1.15 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Actinium Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.14,
with a Debt / Equity ratio of 0.05.
Current Ratio 9.14 Quick Ratio 9.14 Debt / Equity 0.05 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.23M Employee Count 31 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -11.67% in the
last 52 weeks. The beta is -0.3, so Actinium Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.3 52-Week Price Change -11.67% 50-Day Moving Average 1.66 200-Day Moving Average 1.45 Relative Strength Index (RSI) 46.87 Average Volume (20 Days) 248,082
Income Statement
Revenue n/a Gross Profit -811K Operating Income -42.12M Net Income -38.24M EBITDA -37.43M EBIT -38.24M Earnings Per Share (EPS) -1.27
Full Income Statement Balance Sheet The company has 72.9M in cash and 1.57M in
debt, giving a net cash position of 71.33M.
Cash & Cash Equivalents 72.9M Total Debt 1.57M Net Cash 71.33M Retained Earnings -375.83M Total Assets 63.02M Working Capital 52.72M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -33.07M
and capital expenditures -11K, giving a free cash flow of -33.08M.
Operating Cash Flow -33.07M Capital Expenditures -11K Free Cash Flow -33.08M FCF Per Share -1.1
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ATNM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATNM is $4.5,
which is 183% higher than the current price. The consensus rating is "Buy".
Price Target $4.5 Price Target Difference 183% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 11, 2020. It was a
backward
split with a ratio of 1:30.
Last Split Date Aug 11, 2020 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -9.48 Piotroski F-Score 2
